Clinical Observation of Transmetil in the Treatment of Impairment of Liver Function after Chemotherapy

LI Rui-chao,ZHENG Li-jun,Fang Ming-hao
DOI: https://doi.org/10.3870/lcxh.j.issn.1005-541X.2011.04.02
2011-01-01
Abstract:Objective To observe the efficacy of transemetil for cancer patients with impairment of liver function after chemotherapy.Methods 75 cancer patients with liver dysfunction after chemotherapy were randomized into two groups.Therapeutic group was treated by transemetil and control group wes treated by essentiale N.Results The effective rates of therapeutic group and control group was 85.3% and 80.6% in decrease of ALT and AST,which was no significance difference in two groups.But the effective rates of therapeutic wes higher than control group significantly in decrease of high-jaundice,P<0.05.There was no obvious side effects observed during therapy.Conclusion Transmetil had obviously curative effect and safety in impairment of liver function after chemotherapy.
What problem does this paper attempt to address?